Glycohistochemical characterization of vascular muscle cell destruction in CADASIL subjects by lectins, neoglycoconjugates and galectin-specific antibodies

Neuropathology and Applied Neurobiology

Volumn 29, Issue 4, 2003, Pages 400-410

  Brulin Fardoux, P ^a   Godfrain, C ^b   Maurage, C A ^a   De Reuck, J ^c   Hauw, J J ^d   Kaltner, H ^e   Bovin, N V ^f   Gabius, H J ^e   Ruchoux, M M ^a   Kiss, Robert ^g   Camby, I ^g  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e UNIVERSITY OF MUNICH   (Germany)

^f SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^g UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

CADASIL; Galectin; Histochemistry; Lectin; Neoglycoconjugate; Oligosaccharide; Vascular muscle cell (VMC)

Indexed keywords

ANTIBODY; FUCOSE; GALACTOSE; GALECTIN ANTIBODY; GLYCAN; GLYCOCONJUGATE; LECTIN; MANNOSE; OLIGOSACCHARIDE; UNCLASSIFIED DRUG;

AGE; ANTIBODY SPECIFICITY; ARTICLE; BIOTINYLATION; BLOOD BRAIN BARRIER; BRAIN; CADASIL; CEREBRAL ARTERY DISEASE; CLINICAL ARTICLE; COMPUTER ANALYSIS; CONTROLLED STUDY; FEMALE; GENDER; HEART; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; KIDNEY; LIVER; LUNG; MALE; MICROSCOPY; MOLECULAR BIOLOGY; NEUROPATHOLOGY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; SMOOTH MUSCLE FIBER; STAINING; SYMPTOM; VASCULAR SMOOTH MUSCLE;

ADULT; ANTIBODY SPECIFICITY; DEMENTIA, MULTI-INFARCT; DISACCHARIDES; FEMALE; GALECTINS; GLYCOPROTEINS; HISTOCYTOCHEMISTRY; HUMANS; LECTINS; MALE; MIDDLE AGED; MONOSACCHARIDES; MUSCLE, SMOOTH, VASCULAR;

EID: 0042591130     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.2003.00478.x     Document Type: Article

References (42)

1. Apweiler R, Hermjakob H, Sharon N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochem Biophys Acta 1999; 1473: 4-8
2. Baudrimont M, Dubas F, Joutel A, Tournier-Lasserve E, Bousser MG. Autosomal dominant leukoencephalopathy and subcortical ischemic stroke. A clinicopathological study. Stroke 1993; 24: 122-5
3. Brockhansen I, Schutzbach J, Kuhns W. Glycoproteins and their relationship to human disease. Arch Anat 1998; 161: 36-78
4. Camby I, Belot N, Rorive S, Lefranc F, Maurage CA, Lahm H, Kaltner H, Hadari Y, Ruchoux MM, Brotchi J, Zick Y, Salmon I, Gabius HJ, Kiss R. Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration. Brain Pathol 2001; 11: 12-26
5. Camby I, Decaestecker C, Gordower L et al. Distinct differences in binding capacity to saccharide epitopes in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas. J Neuropathol Exp Neurol 2001; 60: 75-84
6. Camby I, Nagy N, Lopes MB et al. Supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas are characterized by a differential expression of S100 proteins. Brain Pathol 1999; 9: 825-43
7. Cavalot F, Anfossi G, Russo I, Mularoni E, Massuco P, Mattiello L, Burzacca S, Hahn AW, Trovati M. Nonenzymatic glycation of fibronectin impairs adhesive and proliferative properties of human vascular smooth muscle cells. Metabolism 1996; 45: 285-92
8. Chabriat H, Tournier-Lasserve E, Vahedi K et al. Autosomal dominant migraine with MRI white-matter abnormalities mapping to the CADASIL locus. Neurology 1995; 45: 1086-91
9. Debbage PL, Gabius HJ, Bise K, Marguth F. Cellular glycoconjugates and their potential endogenous receptors in cerebral microvasculature of man: a glycohistochemical study. Eur J Cell Biol 1988; 46: 425-34
10. Dichgans M, Mayer M, Uttner I et al. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol 1998; 44: 791-839
11. Elias JM, Gown AM, Nakamura RM et al. Special report: quality control in immunohistochemistry. Am J Clin Pathol 1989; 92: 836-43
12. Estes M, Chimowitz MI, Awad IA, McMahon JT, Furlan AJ, Ratliff NB. Sclerosing vasculopathy of the central nervous system in nonelderly demented patients. Arch Neurol 1991; 48: 631-6
13. Fitzgerald ME, Slapnick SM, Caldwell RB. Alterations in lectin binding accompany increased permeability in the dystrophic rat model for proliferative retinopathy. Prog Clin Biol Res 1989; 314: 409-25
14. Gabius HJ, Gabius S, Zemlyanukhina TV, Bovin NV, Brinck U, Danguy A, Joshi SS, Kayser K, Schottelius J, Sinowatz F et al. Reverse lectin histochemistry: design and application of glycoligands for detection of cell and tissue lectins. Histol Histopathol 1993; 8: 369-83
15. Gabius HJ. Biological information transfer beyond the genetic code: the sugar code. Naturwissenschaften 2000; 87: 108-21
16. Gabius HJ. The how and why of protein-carbohydrate interaction: a primer to the theoretical concept and a guide to application in drug design. Pharm Res 1998; 15: 23-30
17. Guttierrez-Molina M, Caminero-Rodriguez A, Martinez Garcia C, Arpa Gutierrez J, Morales Bastos C, Amer G. Small arterial granular degeneration in familial Binswanger's syndrome. Acta Neuropathol 1994; 87: 98-105
18. Iino K, Yoshinari M, Yamamoto M, Kaku K, Doi Y, Ichikawa K, Iwase M, Fujishima M. Effect of glycated collagen on proliferation of human smooth muscle cells in vitro. Dabetologica 1996; 39: 800-6
19. Joutel A, Andreux F, Gaulis S, Domenga V, Cecillon M, Battail N, Piga N, Chapon F, Godfrain C, Tournier-Lasserve E. The ectodomain of the Notch3 Receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest 2000; 105: 597-605
20. Joutel A, Favrole P, Labauge P et al. Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis. Lancet 2001; 358: 2049-51
21. Joutel A, Vahedi K, Corpechot C, Troesch A, Chabriat H, Vayssiere C, Cruaud C, Macizek J, Weissenbach J, Bousser MG, Bach JF, Tournier-Lasserve E. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet 1997; 350: 1511-15
22. Kadota E, Tanji K, Nishida S, Takahashi M, Maeda M, Hiruma S, Enomoto Y, Hashimoto S, Akai F. Lectin (UEA-1) reaction of capillary endothelium with reference to permeability in autopsied cases of cerebral infarction. Histol Histopathol 1986; 1: 219-26
23. Kalimo H, Ruchoux MM, Viitanen M, Kalaria R, CADASIL: acomon form of hereditary arteriopahty causin braid infarcts and dementia. Brain Pathol 2002; 12: 371-84
24. Kalimo H, Viitanen M, Amberlat K et al. CADASIL: hereditary disease of arteries causing brain infarcts and dementia. Neuropathol Appl Neurobiol 1999; 25: 257-65
25. Lis H, Sharon N. Lectins: carbohydrate-specifc proteins that mediate cellular recognition. Chem Rev 1998; 98: 637-74
26. Malandrini A, Carrera P, Palmeris XX et al. Clinicopathological and genetic studies of two further Italian families with cerebral autosomal dominant arteriopathy. Acta Neuropathol 1996; 92: 116-22
27. Moiseeva EP, Javed Q, Spring EL, Bono DP. Galectin-1 is involved in vascular smooth muscle cell proliferation. Cardiovasc Res 2000; 45: 493-502
28. Nangia-Makker P, Honjo Y, Sarvis R, Akahani S, Hogan V, Pienta KJ, Raz A. Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol 2000; 156: 899-909
29. Perillo NL, Marcus ME, Baum LG. Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J Mol Med 1998; 76: 402-42
30. Plendl J, Sinowatz F, Auerbach R, Gabius HJ. Quantitative differences in neoglycoprotein binding for vascular endothelial cells from porcine brain, ovary and testis in vitro. Microvasc Res 1995; 50: 199-214
31. Ragno M, Tournier-Lasserve E, Fiori M et al. An Italian kindred with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Ann Neurol 1995; 38: 231-6
32. Rickert RR, Maliniak RM. Intralaboratory quality assurance of immunohistochemical procedures. Arch Pathol Laboratory Med 1989; 113: 673-9
33. Rini JM, Lobsanov YD. New animal lectin structures. Curr Opin Struct Biol 1999; 9: 578-84
34. Ruchoux MM, Guerrouaou D, Vandenhaute B, Pruvo JP, Vermersch P, Leys D. Systemic vascular smooth muscle cells impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol 1995; 89: 500-12
35. Ruchoux MM, Maurage CA. CADASIL: cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Neuropathol Exp Neurol 1997; 56: 947-64
36. Ruchoux MM, Maurage CA. Endothelial changes in muscle and skin biopsies in patients with CADASIL. Neuropathol Appl Neurolbiol 1997; 23: 60-5
37. Sabbadini G, Francia A, Calandriello L et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Clinical, neuroimaging, pathological and genetic study of a large Italian family. Brain 1995; 118: 207-15
38. Sanford GL, Harris-Hooker S. Stimulation of vascular cell proliferation by β-galactoside-specific lectins. FASEB J 1990; 4: 2912-18
39. Sourander P, Walinder J. Hereditary multi-infarct dementia. Morphological and clinical studies of a new disease. Acta Neuropathol (Berl) 1977; 39: 247-54
40. Tournier-Lasserve E, Joutel A, Melki J et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to Chromosome 19q12. Nature Genet 1993; 3: 256-9
41. Zanetta JP. Structure and functions of lectins in the central and peripheral nervous system. Acta Anat 1998; 161: 180-95
42. Zhang WW, Ma KC, Andersen O, Sourander P, Tollesson PO, Olson Y. The microvascular changes in cases of hereditary multi-infarct disease in the brain. Acta Nauropathol 1994; 87: 317-24